Thrombolysis of extracranial and intracranial arteries after IV abciximab

Neurology. 2001 Jun 12;56(11):1582-4. doi: 10.1212/wnl.56.11.1582.

Abstract

Abciximab was administered intravenously to three patients to treat thrombus associated with atherosclerotic stenosis of a supra-aortic artery. In two cases, the thrombi had been identified on a previous angiography more than a week before treatment. Successful thrombolysis was achieved with abciximab in all three cases. In this small series, abciximab had a thrombolytic effect on established thrombi that were refractory to previous antithrombotic treatment attempts.

Publication types

  • Case Reports

MeSH terms

  • Abciximab
  • Antibodies, Monoclonal / administration & dosage*
  • Anticoagulants / administration & dosage*
  • Cerebral Angiography
  • Female
  • Humans
  • Immunoglobulin Fab Fragments / administration & dosage*
  • Injections, Intravenous
  • Intracranial Arteriosclerosis / diagnosis
  • Intracranial Arteriosclerosis / therapy
  • Intracranial Thrombosis / diagnosis
  • Intracranial Thrombosis / therapy*
  • Male
  • Middle Aged
  • Thrombolytic Therapy*

Substances

  • Antibodies, Monoclonal
  • Anticoagulants
  • Immunoglobulin Fab Fragments
  • Abciximab